Christos Vaklavas
0000-0002-9919-2748
University of Utah
6 papers found
Refreshing results…
A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer
The association between time-of-day of habitual exercise training and changes in relevant cancer health outcomes among cancer survivors
Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast Cancer
Erratum: “Toward improved models of human cancer” [APL Bioeng. 5, 010901 (2021)]
Toward improved models of human cancer
TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer
Missing publications? Search for publications with a matching author name.